Tirofiban Hydrochloride
Tirofiban hydrochloride is the hydrochloride salt form of tirofiban, a glycoprotein IIb/IIIa receptor antagonist antiplatelet agent used for acute coronary syndromes and stroke prevention. See tirofiban for complete pharmacological details. This salt formulation is used in intravenous preparations for acute cardiovascular and cerebrovascular management.
Masse moléculaire
477,1000 g/mol
TPSA
113,00 Ų
Aires thérapeutiques
Mécanisme d'action
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
Structure 2D
Cite this structure
Embed this structure
SMILES
CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O.Cl.O
InChI
InChI=1S/C22H36N2O5S.ClH.H2O/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18;;/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26);1H;1H2/t21-;;/m0../s1
Molecular Formula
C22H37ClN2O5S
HBD / HBA
4 / 7
Liaisons Rotatives
14
Atomes Lourds
31
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Foire aux questions
Tirofiban hydrochloride is the hydrochloride salt form of tirofiban, a glycoprotein IIb/IIIa receptor antagonist antiplatelet agent used for acute coronary syndromes and stroke prevention. See tirofiban for complete pharmacological details. This salt formulation is used in intravenous preparations for acute cardiovascular and cerebrovascular management.
Competitively binds to its target receptor without activating it, blocking the natural ligand from binding and preventing receptor-mediated signaling.
Yes, Tirofiban Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3189072. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 64781. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tirofiban-hydrochloride"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tirofiban-hydrochloride/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tirofiban-hydrochloride/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tirofiban-hydrochloride/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tirofiban-hydrochloride"></drugfyi-drug>